Global Needle-Free Devices market is projected to expand at a CAGR of 8.5% during the forecast period.
Needle-free drug delivery injects the biologics without pain, anxiety, and want for handling the needles, and therefore the market studied is primarily driven by the prevalence of chronic diseases and technological advancements within the field.
The Needle-Free Devices market is segmented on the lines of its Product, End User, application and regional. The basis of Product the market is segmented into Spring-Loaded Jet Injector, Battery-Powered Jet Injector and Gas-Powered Jet Injector. Based on End User the global Needle-Free Devices market covers Hospitals, Clinics and Others. The Needle-Free Devices market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, and Rest of World. Each geographic market is further segmented to provide market revenue for selected countries such as the U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Competitive Rivalry
Pfizer, Antares Pharma, Vygon (UK) Ltd, Romsons and BD are among the major players in the global Needle-Free Devices market share. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Needle-Free Devices Market has been segmented as below:
Needle-Free Devices Market, By Product
Needle-Free Devices Market, By End User
Needle-Free Devices Market, By Region
The report covers:
Report scope:
The scope of the report includes a detailed study of Needle-Free Devices market with the reasons given for variations in the growth of the industry in certain regions.
The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Pfizer, Antares Pharma, Vygon (UK) Ltd, Romsons and BD. Company profile includes assigning such as company overview, product landscape, financial overview, and recent developments.
The top company reports are intended to provide our buyers with a snapshot of the industry’s most influential players.
Reasons to Buy this Report:
Customization:
We can offer you custom research reports as per client’s special requirements
Below are our new reports:
Cataract Surgery Device Market
Intraocular lens (IOLs) Market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.2.1. Driver 1
4.2.2. Driver 2
4.2.3. Driver 3
4.3. Restraints
4.3.1. Restraint 1
4.3.2. Restraint 2
4.4. Opportunities
4.4.1. Opportunity 1
4.4.2. Opportunity 2
4.5. Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
5. Needle-Free Devices Market, By Product
5.1. Key Points
5.2. Spring-Loaded Jet Injector
5.3. Battery-Powered Jet Injector
5.4. Gas-Powered Jet Injector
6. Needle-Free Devices Market, By End User
6.1. Key Points
6.2. Hospitals
6.3. Clinics
6.4. Others
7. Competitive Landscape
7.1. Introduction
7.2. Recent Developments
7.2.1. Mergers & Acquisitions
7.2.2. New Product Developments
7.2.3. Portfolio/Production Capacity Expansions
7.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
7.2.5. Others
8. Company Profile
(OVERVIEW, KEY FINANCIALS, PRODUCT AND PRODUCT OFFERINGS, RELATED DEVELOPMENTS)
8.1. Pfizer
8.2. Antares Pharma
8.3. Vygon (UK) Ltd
8.4. Romsons
8.5. BD
The Needle-Free Devices Market has been segmented as below:
Needle-Free Devices Market, By Product
Needle-Free Devices Market, By End User
Needle-Free Devices Market, By Region
SUBSCRIBE TO OUR NEWSLETTERS
